FDA-Inspected Site

Lawrence Berkeley National Laboratory IRB

2 FDA inspections are on record for Lawrence Berkeley National Laboratory IRB in Berkeley, United States.

Clean· No action indicated

Berkeley, United States · Last updated August 15, 2026

Overview

  • 2 FDA inspections are on record.
  • 1 inspection produced a Form 483.
  • The most recent recorded inspection date is 2026-02-13.

At a glance

Inspections

2

Form 483s

1

EIRs

0

Last outcome

Clean

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
9 Feb 2026 – 13 Feb 2026Human DrugsClean
8 Sep 2017 – 21 Sep 2017Human Drugs483View 483 →

Observations on record

Form 483 observations cited at this site, most recent first.

21 Sep 2017
21 CFR 361.1(c)(2)

Numerical votes not in the minutes of any RDRC meetings

Cited by Sandra S Saniga

21 Sep 2017
21 CFR 361.1(c)(3)

FDA research proposals not reported +30 subjects

Cited by Sandra S Saniga

21 Sep 2017
21 CFR 361.1(c)(2)

RDRC did not meet at least once each quarter

Cited by Sandra S Saniga

21 Sep 2017
21 CFR 361.1(c)(2)

Signatures of RDRC Chairman

Cited by Sandra S Saniga

21 Sep 2017
21 CFR 361.1(f)(1)

Packaging, labeling - Rx only

Cited by Sandra S Saniga

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 361.1(c)(2)Cited across public-safe Form 483 observations3x
21 CFR 361.1(c)(3)Cited across public-safe Form 483 observations1x
21 CFR 361.1(f)(1)Cited across public-safe Form 483 observations1x
21 CFR 361.1(f)(5)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Lawrence Berkeley National Laboratory IRB's 1 Form 483

Verbatim observations and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat